ResMed Inc. (RMD)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 177.61 |
| Open | 179.15 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1000 |
| Day's range | 176.92 - 179.43 |
| 52-week range | 132.24 - 243.52 |
| Volume | |
| Avg. volume | 1,046,104 |
| Market cap | 26.307B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | 29.61 |
| EPS (TTM) | 6.04 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | 1.92 (1.08%) |
| Ex-dividend date | 07 Feb 2024 |
| 1y target est | 202.68 |
Investor's Business DailyHow The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
ResMed stock jumped Thursday after an analyst suggested the growing popularity of weight-loss drugs could drive use of its medical devices.
ZacksResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investor's Business DailyEli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test
Eli Lilly stock popped Wednesday after the company's weight-loss drug significantly reduced nighttime sleep apnea events.
© 2024 Yahoo. All rights reserved.